Joinn Laboratories (06127) achieved a net profit attributable to the parent company of 80.7061 million yuan in the first three quarters, turning losses into profits on a year-on-year basis.

date
23:13 30/10/2025
avatar
GMT Eight
Zhao Yan New Drugs (06127) announced that the group achieved operating income of 985 million yuan in the first three quarters of 2025,...
Joinn Laboratories (06127) announced that in the first three quarters of 2025, the group achieved operating income of 985 million yuan, a decrease of 26.23% year-on-year; net profit attributable to the parent company was 80.7061 million yuan, compared to a loss of 70.3071 million yuan in the same period last year; basic earnings per share was 0.11 yuan.